| What: | Fabrinet Third Quarter Fiscal Year 2026 Financial Results Call | |||||||
| When: | May 4, 2026 | |||||||
| Time: | 5:00 p.m. ET | |||||||
| Live Call and Replay: | https://investor.fabrinet.com/events-and-presentations/events | |||||||
| (in thousands of U.S. dollars, except share data and par value) | March 27, 2026 | June 27, 2025 | |||||||||
| (unaudited) | |||||||||||
| Assets | |||||||||||
| Current assets | |||||||||||
| Cash and cash equivalents | $ | 356,562 | $ | 306,425 | |||||||
| Short-term investments | 588,674 | 627,819 | |||||||||
Trade accounts receivable, net of allowance for expected credit losses of $1,181 and $1,344, respectively | 908,544 | 758,894 | |||||||||
| Inventories | 875,988 | 581,015 | |||||||||
| Prepaid expenses | 38,196 | 38,476 | |||||||||
| Other current assets | 177,476 | 116,210 | |||||||||
| Total current assets | 2,945,440 | 2,428,839 | |||||||||
| Non-current assets | |||||||||||
| Long-term restricted cash | 694 | — | |||||||||
| Property, plant and equipment, net | 524,973 | 380,640 | |||||||||
| Intangibles, net | 2,392 | 2,156 | |||||||||
| Operating right-of-use assets | 4,434 | 5,768 | |||||||||
| Deferred tax assets | 17,266 | 13,406 | |||||||||
| Other non-current assets | 13,787 | 623 | |||||||||
| Total non-current assets | 563,546 | 402,593 | |||||||||
| Total Assets | $ | 3,508,986 | $ | 2,831,432 | |||||||
| Liabilities and Shareholders’ Equity | |||||||||||
| Current liabilities | |||||||||||
| Trade accounts payable | 859,004 | 637,417 | |||||||||
| Fixed assets payable | 65,307 | 40,781 | |||||||||
| Operating lease liabilities, current portion | 1,462 | 1,792 | |||||||||
| Income tax payable | 7,611 | 7,939 | |||||||||
| Accrued payroll, bonus and related expenses | 30,845 | 24,566 | |||||||||
| Accrued expenses | 36,418 | 30,630 | |||||||||
| Severance liabilities, current portion | 1,981 | — | |||||||||
| Other payables | 152,915 | 66,717 | |||||||||
| Total current liabilities | 1,155,543 | 809,842 | |||||||||
| Non-current liabilities | |||||||||||
| Deferred tax liability | 1,216 | 1,595 | |||||||||
| Operating lease liability, non-current portion | 2,963 | 3,679 | |||||||||
| Severance liabilities | 31,501 | 31,225 | |||||||||
| Other non-current liabilities | 13,052 | 3,279 | |||||||||
| Total non-current liabilities | 48,732 | 39,778 | |||||||||
| Total Liabilities | 1,204,275 | 849,620 | |||||||||
| Shareholders’ equity | |||||||||||
Preferred shares (5,000,000 shares authorized, $0.01 par value; no shares issued and outstanding as of March 27, 2026 and June 27, 2025) | — | — | |||||||||
Ordinary shares (500,000,000 shares authorized, $0.01 par value; 39,717,065 shares and 39,602,152 shares issued as of March 27, 2026 and June 27, 2025, respectively; and 35,829,221 shares and 35,728,074 shares outstanding as of March 27, 2026 and June 27, 2025, respectively) | 397 | 396 | |||||||||
| Additional paid-in capital | 243,038 | 237,881 | |||||||||
| Less: Treasury shares (3,887,844 shares and 3,874,078 shares as of March 27, 2026 and June 27, 2025, respectively) | (365,287) | (360,056) | |||||||||
| Accumulated other comprehensive income (loss) | (501) | 10,294 | |||||||||
| Retained earnings | 2,427,064 | 2,093,297 | |||||||||
| Total Shareholders’ Equity | 2,304,711 | 1,981,812 | |||||||||
| Total Liabilities and Shareholders’ Equity | $ | 3,508,986 | $ | 2,831,432 | |||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (in thousands of U.S. dollars, except per share data) | March 27, 2026 | March 28, 2025 | March 27, 2026 | March 28, 2025 | |||||||||||||||||||
| Revenues | $ | 1,214,293 | $ | 871,799 | $ | 3,325,309 | $ | 2,509,635 | |||||||||||||||
| Cost of revenues | (1,069,954) | (769,616) | (2,926,849) | (2,207,577) | |||||||||||||||||||
| Gross profit | 144,339 | 102,183 | 398,460 | 302,058 | |||||||||||||||||||
| Selling, general and administrative expenses | (24,295) | (22,063) | (69,822) | (65,300) | |||||||||||||||||||
| Restructuring and other related costs | — | (1,264) | — | (1,367) | |||||||||||||||||||
| Operating income | 120,044 | 78,856 | 328,638 | 235,391 | |||||||||||||||||||
| Interest income | 7,421 | 10,145 | 25,393 | 32,392 | |||||||||||||||||||
| Foreign exchange gain (loss), net | 6,989 | (2,675) | 1,715 | (5,728) | |||||||||||||||||||
| Other income (expense), net | (212) | (30) | (351) | (111) | |||||||||||||||||||
| Income before income taxes | 134,242 | 86,296 | 355,395 | 261,944 | |||||||||||||||||||
| Income tax expense | (9,029) | (5,006) | (21,628) | (16,624) | |||||||||||||||||||
| Net income | 125,213 | 81,290 | 333,767 | 245,320 | |||||||||||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
| Change in net unrealized gain (loss) on available-for-sale securities | (2,966) | 3,350 | (1,325) | 9,647 | |||||||||||||||||||
| Change in net unrealized gain (loss) on derivative instruments | (11,946) | 1,790 | (9,382) | 907 | |||||||||||||||||||
| Change in foreign currency translation adjustment | (28) | 1,060 | (88) | 1,136 | |||||||||||||||||||
| Total other comprehensive income (loss), net of tax | (14,940) | 6,200 | (10,795) | 11,690 | |||||||||||||||||||
| Net comprehensive income | $ | 110,273 | $ | 87,490 | $ | 322,972 | $ | 257,010 | |||||||||||||||
| Earnings per share | |||||||||||||||||||||||
| Basic | $ | 3.49 | $ | 2.26 | $ | 9.32 | $ | 6.80 | |||||||||||||||
| Diluted | $ | 3.45 | $ | 2.25 | $ | 9.22 | $ | 6.75 | |||||||||||||||
Weighted-average number of ordinary shares outstanding (in thousands of shares) | |||||||||||||||||||||||
| Basic | 35,828 | 35,914 | 35,809 | 36,094 | |||||||||||||||||||
| Diluted | 36,301 | 36,172 | 36,217 | 36,327 | |||||||||||||||||||
| Nine Months Ended | |||||||||||
| (in thousands of U.S. dollars) | March 27, 2026 | March 28, 2025 | |||||||||
| Cash flows from operating activities | |||||||||||
| Net income for the period | $ | 333,767 | $ | 245,320 | |||||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||||||||
| Depreciation and amortization | 48,761 | 39,223 | |||||||||
| (Gain) loss on disposal of property, plant and equipment and intangibles | 45 | (39) | |||||||||
| Amortization of discount (premium) of short-term investments | (3,622) | (3,435) | |||||||||
| Inventory obsolescence impairment | 2,389 | — | |||||||||
| (Reversal of) allowance for expected credit losses | (163) | (374) | |||||||||
| Unrealized loss (gain) on exchange rate and fair value of foreign currency forward contracts | (3,544) | 4,067 | |||||||||
| Share-based compensation | 26,369 | 24,903 | |||||||||
| Customer warrant | 3,177 | 3,929 | |||||||||
| Deferred income tax expense (benefit) | (3,333) | (4,182) | |||||||||
| Other non-cash expenses | 285 | 82 | |||||||||
| Changes in operating assets and liabilities | |||||||||||
| Trade accounts receivable | (150,082) | (65,271) | |||||||||
| Inventories | (297,362) | (68,132) | |||||||||
| Other current assets and non-current assets | (77,518) | (2,357) | |||||||||
| Trade accounts payable | 225,741 | 79,196 | |||||||||
| Income tax payable | (328) | 4,180 | |||||||||
| Accrued expenses | (5,539) | 12,643 | |||||||||
| Other payables | 91,155 | (152) | |||||||||
| Severance liabilities | 2,663 | 2,131 | |||||||||
| Other current liabilities and non-current liabilities | 8,897 | 1,540 | |||||||||
| Net cash provided by operating activities | 201,758 | 273,272 | |||||||||
| Cash flows from investing activities | |||||||||||
| Purchase of short-term investments | (241,255) | (304,189) | |||||||||
| Proceeds from maturities of short-term investments | 282,697 | 122,129 | |||||||||
| Purchase of property, plant and equipment | (160,634) | (70,668) | |||||||||
| Purchase of intangibles | (682) | (514) | |||||||||
| Proceeds from disposal of property, plant and equipment | 57 | 116 | |||||||||
| Net cash used in investing activities | (119,817) | (253,126) | |||||||||
| Cash flows from financing activities | |||||||||||
| Repurchase of ordinary shares | (5,231) | (103,475) | |||||||||
| Withholding tax related to net share settlement of restricted share units | (24,388) | (20,918) | |||||||||
| Net cash used in financing activities | (29,619) | (124,393) | |||||||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | $ | 52,322 | $ | (104,247) | |||||||
| Movement in cash, cash equivalents and restricted cash | |||||||||||
| Cash, cash equivalents and restricted cash at the beginning of period | $ | 306,425 | $ | 409,973 | |||||||
| Increase (decrease) in cash, cash equivalents and restricted cash | 52,322 | (104,247) | |||||||||
| Effect of exchange rate on cash, cash equivalents and restricted cash | (1,491) | 1,179 | |||||||||
| Cash, cash equivalents and restricted cash at the end of period | $ | 357,256 | $ | 306,905 | |||||||
| Non-cash investing and financing activities | |||||||||||
| Construction, software and equipment-related payables | $ | 65,307 | $ | 33,101 | |||||||
| As of | |||||||||||
| (in thousands of U.S. dollars) | March 27, 2026 | March 28, 2025 | |||||||||
| Cash and cash equivalents | $ | 356,562 | $ | 306,905 | |||||||
| Restricted cash | 694 | — | |||||||||
| Cash, cash equivalents and restricted cash | $ | 357,256 | $ | 306,905 | |||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars) | March 27, 2026 | March 28, 2025 | March 27, 2026 | March 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||
| Revenues | $ | 1,214,293 | $ | 871,799 | $ | 3,325,309 | $ | 2,509,635 | |||||||||||||||||||||||||||||||||||||||
| Gross profit (GAAP) | $ | 144,339 | 11.9 | % | $ | 102,183 | 11.7 | % | $ | 398,460 | 12.0 | % | $ | 302,058 | 12.0 | % | |||||||||||||||||||||||||||||||
| Share-based compensation expenses | 2,531 | 2,221 | 8,694 | 7,883 | |||||||||||||||||||||||||||||||||||||||||||
| Gross profit (Non-GAAP) | $ | 146,870 | 12.1 | % | $ | 104,404 | 12.0 | % | $ | 407,154 | 12.2 | % | $ | 309,941 | 12.4 | % | |||||||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars) | March 27, 2026 | March 28, 2025 | March 27, 2026 | March 28, 2025 | |||||||||||||||||||||||||||||||||||||||||||
| Revenues | $ | 1,214,293 | $ | 871,799 | $ | 3,325,309 | $ | 2,509,635 | |||||||||||||||||||||||||||||||||||||||
| Operating profit (GAAP) | $ | 120,044 | 9.9 | % | $ | 78,856 | 9.0 | % | $ | 328,638 | 9.9 | % | $ | 235,391 | 9.4 | % | |||||||||||||||||||||||||||||||
| Share-based compensation expenses | 8,541 | 7,783 | 26,369 | 24,903 | |||||||||||||||||||||||||||||||||||||||||||
| Legal and litigation costs | 497 | 827 | 1,007 | 827 | |||||||||||||||||||||||||||||||||||||||||||
| Severance payment and others | 613 | — | 685 | 748 | |||||||||||||||||||||||||||||||||||||||||||
| Restructuring and other related costs | — | 1,264 | — | 1,367 | |||||||||||||||||||||||||||||||||||||||||||
| Operating profit (Non-GAAP) | $ | 129,695 | 10.7 | % | $ | 88,730 | 10.2 | % | $ | 356,699 | 10.7 | % | $ | 263,236 | 10.5 | % | |||||||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
| March 27, 2026 | March 28, 2025 | March 27, 2026 | March 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars, except per share data) | Net income | Diluted EPS | Net income | Diluted EPS | Net income | Diluted EPS | Net income | Diluted EPS | |||||||||||||||||||||||||||||||||||||||
| GAAP measures | $ | 125,213 | $ | 3.45 | $ | 81,290 | $ | 2.25 | $ | 333,767 | $ | 9.22 | $ | 245,320 | $ | 6.75 | |||||||||||||||||||||||||||||||
| Items reconciling GAAP net income & EPS to non-GAAP net income & EPS: | |||||||||||||||||||||||||||||||||||||||||||||||
| Related to cost of revenues: | |||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expenses | 2,531 | 0.07 | 2,221 | 0.06 | 8,694 | 0.24 | 7,883 | 0.22 | |||||||||||||||||||||||||||||||||||||||
| Total related to cost of revenues | 2,531 | 0.07 | 2,221 | 0.06 | 8,694 | 0.24 | 7,883 | 0.22 | |||||||||||||||||||||||||||||||||||||||
| Related to selling, general and administrative expenses: | |||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expenses | 6,010 | 0.16 | 5,562 | 0.16 | 17,675 | 0.48 | 17,020 | 0.47 | |||||||||||||||||||||||||||||||||||||||
| Legal and litigation costs | 497 | 0.02 | 827 | 0.02 | 1,007 | 0.03 | 827 | 0.02 | |||||||||||||||||||||||||||||||||||||||
| Severance payment and others | 613 | 0.02 | — | — | 685 | 0.02 | 748 | 0.02 | |||||||||||||||||||||||||||||||||||||||
| Total related to selling, general and administrative expenses | 7,120 | 0.20 | 6,389 | 0.18 | 19,367 | 0.53 | 18,595 | 0.51 | |||||||||||||||||||||||||||||||||||||||
| Related to other income and expense: | |||||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and other related costs | — | — | 1,264 | 0.03 | — | — | 1,367 | 0.04 | |||||||||||||||||||||||||||||||||||||||
| Total related to other income and expense | — | — | 1,264 | 0.03 | — | — | 1,367 | 0.04 | |||||||||||||||||||||||||||||||||||||||
| Total related to net income & EPS | 9,651 | 0.27 | 9,874 | 0.27 | 28,061 | 0.77 | 27,845 | 0.77 | |||||||||||||||||||||||||||||||||||||||
| Non-GAAP measures | $ | 134,864 | $ | 3.72 | $ | 91,164 | $ | 2.52 | $ | 361,828 | $ | 9.99 | $ | 273,165 | $ | 7.52 | |||||||||||||||||||||||||||||||
| Shares used in computing diluted net income per share (in thousands of shares) | |||||||||||||||||||||||||||||||||||||||||||||||
| GAAP diluted shares | 36,301 | 36,172 | 36,217 | 36,327 | |||||||||||||||||||||||||||||||||||||||||||
| Non-GAAP diluted shares | 36,301 | 36,172 | 36,217 | 36,327 | |||||||||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars) | Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
| March 27, 2026 | March 28, 2025 | March 27, 2026 | March 28, 2025 | |||||||||||||||||||||||
| Net cash provided by operating activities | $ | 52,931 | $ | 74,186 | $ | 201,758 | $ | 273,272 | ||||||||||||||||||
| Less: Purchase of property, plant and equipment | (63,760) | (28,518) | (160,634) | (70,668) | ||||||||||||||||||||||
| Non-GAAP free cash flow | $ | (10,829) | $ | 45,668 | $ | 41,124 | $ | 202,604 | ||||||||||||||||||
Diluted EPS | |||||
| GAAP net income per diluted share | $3.48 to $3.63 | ||||
| Related to cost of revenues: | |||||
| Share-based compensation expenses | 0.08 | ||||
| Total related to cost of revenues | 0.08 | ||||
| Related to selling, general and administrative expenses: | |||||
| Share-based compensation expenses | 0.16 | ||||
| Total related to selling, general and administrative expenses | 0.16 | ||||
| Total related to net income & EPS | 0.24 | ||||
| Non-GAAP net income per diluted share | $3.72 to $3.87 | ||||